» Articles » PMID: 16146777

Tissue Transglutaminase (TG2)--a Wound Response Enzyme

Overview
Journal Front Biosci
Specialty Biology
Date 2005 Sep 9
PMID 16146777
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Repair of tissue after injury depends on a series of concerted but overlapping events including, inflammation, re-epithelialization, neovascularization and synthesis and stabilization of a fibrous extracellular matrix (ECM) that is remodeled to emulate normal tissue over time. Particular members of the transglutaminase (TG) family are upregulated during wound healing and act as a novel class of wound-healing mediators during the repair process. This group of enzymes which crosslink proteins via epsilon(gamma-glutamyl) lysine bridges are involved in wound healing through their ability to stabilize proteins and also by regulating the behavior of a wide variety of cell types that are recruited to the damaged area in order to carry out tissue repair. In this article we discuss the function of the most widely expressed member of the TG family "tissue transglutaminase" (TG2) in wound repair. Using both early and recent evidence from the literature we demonstrate how the multifunctional TG2 affects the stability of the ECM, cell-ECM interactions and as a consequence cell behavior within the different phases of wound healing, and highlight how TG2 itself might be exploited for therapeutic use.

Citing Articles

Human amniotic membrane modulates collagen production and deposition in vitro.

Moreno S, Enwerem-Lackland I, Dreaden K, Massee M, Koob T, Harper J Sci Rep. 2024; 14(1):15998.

PMID: 38987293 PMC: 11237048. DOI: 10.1038/s41598-024-64364-2.


Shaping Oncogenic Microenvironments: Contribution of Fibronectin.

Guerrero-Barbera G, Burday N, Costell M Front Cell Dev Biol. 2024; 12:1363004.

PMID: 38660622 PMC: 11039881. DOI: 10.3389/fcell.2024.1363004.


Molecular Basis of Transglutaminase-2 and Muscarinic Cholinergic Receptors in Experimental Myopia: A Target for Myopia Treatment.

Barathi V, Ho C, Tong L Biomolecules. 2023; 13(7).

PMID: 37509081 PMC: 10377462. DOI: 10.3390/biom13071045.


Transglutaminases are oncogenic biomarkers in human cancers and therapeutic targeting of TGM2 blocks chemoresistance and macrophage infiltration in pancreatic cancer.

Zhang S, Yao H, Li H, Su T, Jiang S, Wang H Cell Oncol (Dordr). 2023; 46(5):1473-1492.

PMID: 37246171 DOI: 10.1007/s13402-023-00824-7.


Glycomimetic Peptides as Therapeutic Tools.

Hoober J, Eggink L Pharmaceutics. 2023; 15(2).

PMID: 36840010 PMC: 9966187. DOI: 10.3390/pharmaceutics15020688.